Evidence map›Paper›PMID 40163056›Full record

ArticleJournal of acquired immune deficiency syndromes (1999)2025

Generating Evidence for Effective HIV Implementation at Scale: The Value and Feasibility of a Network for Implementation Science in HIV.

Sheree Schwartz, Nanette Benbow, Russell A Brewer, Laura K Beres, Debbie L Humphries, Latesha E Elopre, Sung-Jae Lee, Maile Y Karris, Joseph G Rosen, Jessica Kassanits and 9 more

Abstract read
In one paragraph

Article in Journal of acquired immune deficiency syndromes (1999), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors.

Sheree SchwartzDepartment of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD.
Nanette BenbowThird Coast Center for AIDS Research and Department of Psychiatry and Behavioral Sciences, Northwestern University, Chicago, IL.
Russell A BrewerDepartment of Medicine, University of Chicago, Chicago, IL.
Laura K BeresDepartment of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD.
Debbie L HumphriesCenter for Methods in Implementation and Prevention Science, Yale School of Public Health, New Haven, CT.
Latesha E ElopreDepartment of Medicine, University of Alabama at Birmingham, Birmingham, AL.
Sung-Jae LeeCenter for HIV Identification, Prevention and Treatment Services (CHIPTS), Department of Psychiatry and Biobehavioral Sciences, David Geffen School of Medicine at UCLA, University of California, Los Angeles, Los Angeles, CA.
Maile Y KarrisDepartment of Medicine, University of California, San Diego, San Diego, CA.
Joseph G RosenDepartment of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD.
Jessica KassanitsInstitute for Sexual and Gender Minority Health and Wellbeing (ISGMH), Northwestern University, Chicago, IL.
Aadia RanaDepartment of Medicine, University of Alabama-Birmingham Heersink School of Medicine, Birmingham, AL.
Jill BlumenthalDivision of Infectious Diseases, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD.
Joyce L JonesDepartment of Health Behavior, School of Public Health, University of Alabama at Birmingham (UAB), Birmingham, AL.
Robin Gaines LanziDepartment of Health Behavior, School of Public Health, University of Alabama at Birmingham (UAB), Birmingham, AL.
Uyen KaoDepartment of Family Medicine, University of California, Los Angeles, Los Angeles, CA.
Tequetta ValerianoYale School of Nursing, Orange, CT.
Alison HamiltonCenter for HIV Identification, Prevention and Treatment Services (CHIPTS), Department of Psychiatry and Biobehavioral Sciences, David Geffen School of Medicine at UCLA, University of California, Los Angeles, Los Angeles, CA.
Brian MustanskiThird Coast Center for AIDS Research and Department of Medical Social Sciences, Northwestern University, Chicago, IL; and.
Sten H VermundYale School of Public Health, New Haven, CT.

Funding

VirologyP30AI036214 · NIAID · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI SUSAN JANET LITTLE · 1994 to 2026
$78.4M
Vaccine Response and Immunotherapeutics SWGP30AI094189 · NIAID · JOHNS HOPKINS UNIVERSITY · PI Anna Palmer Durbin · 2012 to 2026
$67.0M
UCLA Rapid, Relevant, Rigorous Implementation Science HubP30MH058107 · NIMH · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI Sung-Jae Lee · 1997 to 2026
$53.5M
Using Coincidence Analysis to Investigate Factors Affecting PrEP Initiation and Continuation in Southern ending the Epidemic CountiesP30MH062294 · NIMH · YALE UNIVERSITY · PI Trace S Kershaw · 2001 to 2026
$48.5M
Virology and Immunology Technology CoreP30AI117943 · NIAID · NORTHWESTERN UNIVERSITY AT CHICAGO · PI Sahera Dirajlal-Fargo · 2015 to 2026
$38.4M
The Brown Initiative in HIV and AIDS Clinical Research for Minority CommunitiesR25MH083620 · NIMH · MIRIAM HOSPITAL · PI NUNN, AMY STEWART · 2008 to 2025
$3.7M
NIAID NIH HHS P30 AI036214NIAID NIH HHS P30 AI094189NIAID NIH HHS P30 AI117943NIMH NIH HHS P30 MH058107NIMH NIH HHS P30 MH062294NIMH NIH HHS R25 MH083620
6 · The paper itself

Abstract

abstractThe Network for Implementation Science in HIV (NISH) was established to conduct multisite research to study real-world implementation of evidence-based HIV interventions across US contexts, and to generate generalizable knowledge around implementation strategies to support the achievement of Ending the HIV Epidemic goals. NISH sites represent diverse Ending the HIV Epidemic priority jurisdictions and include participation of multiple units within those sites (eg, multiple clinics and community-based organizations) and bring together research teams from multiple backgrounds within implementation science and the HIV service sector. We argue and provide examples of how NISH studies have and can contribute to the context versus generalizability debate, generate power in numbers, and synthesize, develop, and test implementation strategies that advance both effectiveness and equity. To date, the network has conducted observational studies exploring ongoing implementation and determinants across contexts, and the identification and codesign of strategies to be leveraged in future work. The next stage of network evolution is to leverage this infrastructure to test implementation strategies through nimble study designs built for fast-changing evidence and implementation environments. We argue that the initial successes of NISH warrant future investment to efficiently capitalize on developed infrastructure and optimize science that can effectively be scaled up to address our most critical questions to end the HIV epidemic and support communities most affected.

Indexed as

HIV InfectionsImplementation ScienceHumansUnited States

Identifiers

PMID40163056
PMCPMC13005916

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.